- Home
- Companies
- north america
- ischemic heart
Refine by
Ischemic Heart Suppliers In North America
6 companies found
based inCalgary, ALBERTA (CANADA)
Circle improves patient outcome by revolutionizing the cardiovascular healthcare industry through innovation, and enabling healthcare providers to complete effective and precise analysis. The Global Leader in Cardiac Imaging Solutions. Physicians ...
cvi42 for Cardiac MRI has the most clinically cleared tools for diagnosis, and the most accurate tools to quantify and qualify for research purposes. ...
based inCarlsbad, CALIFORNIA (USA)
CeloNova BioSciences, Inc. is developer and manufacturer of a portfolio of novel surfaced coated technologies, including the proprietary Polyzene-F nanocoating. This next-generation nanocoating is the result of years of rigorous scientific research ...
based inLeiden, NETHERLANDS
Medis was created in 1989 as a spin-off of the Leiden University Medical Centre (LUMC Netherlands). Our founder and current CSO, Hans Reiber, built the company focusing on X-ray and image analysis of the heart with the mission to make these tools ...
The innovative, vendor-independent post-processing software solution for advanced quantitative analysis of cardiovascular CT ...
based inGaithersburg, MARYLAND (USA)
Established in 1992, Medispec is a leading medical device manufacturing company. It was created when the founder, CEO Avner Spector, saw an opportunity to raise the quality of life of people around him. Technically trained as a mechanical engineer, ...
The ESMR therapy is a non-invasive therapy approach using Extracorporeal Shockwave technology for Myocardial Revascularization. Ischemic myocardial areas no longer accessible by conventional revascularization therapies could be treated with the ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Hydrochlorothiazide (HCTZ), an orally active diuretic agent of the thiazide class, inhibits transforming TGF-β/Smad signaling pathway. Hydrochlorothiazide has direct vascular relaxant effects via opening of the calcium-activated potassium (KCA) ...
based inSunnyvale, CALIFORNIA (USA)
We are developing cellular and cell-derived therapeutics for the treatment of unmet cardiovascular and pulmonary diseases. Our Mission: To improve the lives of patients with cardiovascular and pulmonary diseases through the development of ...
The investigational CardiAMP™ Cell Therapy is designed to be a comprehensive biotherapeutic heart failure solution, incorporating: a proprietary molecular diagnostic to characterize the potency of a patient’s own bone marrow cells and ...